CLINICAL TRIALS PROFILE FOR COCAINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for COCAINE HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000187 ↗ | Ritanserin in Treatment of Cocaine Dependence - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1992-07-01 | The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence. |
NCT00000187 ↗ | Ritanserin in Treatment of Cocaine Dependence - 1 | Completed | University of Pennsylvania | Phase 2 | 1992-07-01 | The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence. |
NCT00000188 ↗ | Selegiline in Treatment of Cocaine Dependence - 2 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1994-09-01 | The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for COCAINE HYDROCHLORIDE
Condition Name
Clinical Trial Locations for COCAINE HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for COCAINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for COCAINE HYDROCHLORIDE
Sponsor Name